Model System to Define Pharmacokinetic Requirements for Antimalarial Drug Efficacy

Science Translational Medicine - United States
doi 10.1126/scitranslmed.3006684
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

A Machine Learning Approach to Define Antimalarial Drug Action From Heterogeneous Cell-Based Screens

2019English

Hollow-Fiber Methodology for Pharmacokinetic/Pharmacodynamic Studies of Antimalarial Compounds

Current protocols in chemical biology
Medicine
2016English

Using Genetic Methods to Define the Targets of Compounds With Antimalarial Activity

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

A Biosynthetic Platform for Antimalarial Drug Discovery

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2020English

Hemozoin and Antimalarial Drug Discovery

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Mechanistic Multi‐scale Pharmacokinetic Model for the Anticancer Drug Gemcitabine in Pancreatic Cancer

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2020English

Antimalarial Drug Quality in Africa

Journal of Clinical Pharmacy and Therapeutics
Pharmacology
2007English

Development, Evaluation, and Application of an in Silico Model for Antimalarial Drug Treatment and Failure

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

A Methodology to Define QoS and SLA Requirements in Service Choreographies

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy